Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-03, Stock:JNJ, The news for the past five days is as follows:
2019-06-26: NEWS1: Pacira Gets EMA Acceptance for Pain Management Drug Exparel.NEWS2: Will Democrats Slam Drug Prices? Health Care Stocks Dive Ahead Of Debate.NEWS3: Noteworthy Wednesday Option Activity: ISRG, JNJ, STX.NEWS4: Noteworthy Wednesday Option Activity: ISRG, JNJ, STX.NEWS5: Morphic Holding IPO: What You Need To Know.NEWS6: 3 Top-Performing Large-Cap Stocks.NEWS7: Dow Movers: MRK, INTC.NEWS8: Dow Movers: MRK, INTC.NEWS9: How JNJ and Gilead Are Working to Expand Their Portfolios.NEWS10: Here Are Johnson & Johnson’s Key Growth Drivers in Fiscal 2019.NEWS11: Israeli health tech startup DayTwo raises $31 million.NEWS12: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS13: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS14: 3 Biopharma Stocks to Buy for Income.NEWS15: 3 Biopharma Stocks to Buy for Income.
2019-06-27: NEWS1: Bayer Roundup Legal Adviser Known for Fighting, Not Settling.NEWS2: IWD, JNJ, WMT, MDT: Large Inflows Detected at ETF.NEWS3: IWD, JNJ, WMT, MDT: Large Inflows Detected at ETF.NEWS4: First Democratic Debate Eases Worry Over a Health-Insurance Overhaul.NEWS5: Lightning Strikes Boeing Once Too Often.
2019-06-28: NEWS1: Boston Scientific May Be Too Rich for Johnson & Johnson.NEWS2: J&J's Darzalex Gets FDA Nod for First-Line Multiple Myeloma.NEWS3: J&J's Darzalex Gets FDA Nod for First-Line Multiple Myeloma.NEWS4: Highly Rated Biotech Downgraded After Breaking Out And Running 39%.NEWS5: J&J's Darzalex Gets FDA Nod for First-Line Multiple Myeloma.NEWS6: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.NEWS7: Can Roche's #1 Therapeutic Area With $28 Billion In Revenue Grow Further?.NEWS8: Can Roche's #1 Therapeutic Area With $28 Billion In Revenue Grow Further?.NEWS9: Martin Gilbert branches out.
2019-07-01: NEWS1: Johnson & Johnson: Key Points to Watch on the Charts.NEWS2: Health Care Sector Update for 07/01/2019: TLSA, BCYC, CERC, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Health Care Sector Update for 07/01/2019: TLSA, BCYC, CERC, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Arcturus Metabolic Disorder Candidate Gets Orphan Drug Status.NEWS5: 3 Small-Cap Biotech Stocks That Soared Last Week.
2019-07-02: NEWS1: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS2: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS3: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS4: 10 Stocks That Should Be Every Young Investor’s First Choice.NEWS5: HDV, HUSE: Big ETF Outflows.NEWS6: HDV, HUSE: Big ETF Outflows.NEWS7: Drugmakers raised prices of over 40 prescription drugs.NEWS8: Health Care Sector Update for 07/02/2019: AMRN, CUR, IOVA, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 07/02/2019: AMRN, CUR, IOVA, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 03, 2019.NEWS11: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 03, 2019.

Answer: Rise